Literature DB >> 30415318

Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.

Ronnyson Susano Grativvol1, Wagner Cid Palmeira Cavalcante1, Luiz Henrique Martins Castro1, Ricardo Nitrini1, Mateus Mistieri Simabukuro2,3.   

Abstract

The disorders of the central nervous system associated with cancer by remote immune-mediated mechanisms are a heterogeneous group. These disorders encompass the classic paraneoplastic disorders and the recently recognized autoimmune encephalitis associated with antibodies against neuronal cell surface or synaptic proteins that occur with or without cancer association. In the last decade, the new surge of interest in neuronal diseases associated with anti-neuronal antibodies led to the rapid discovery of new forms of disease that have different manifestations and were not previously suspected to be immune mediated. The recognition of these syndromes is important because it may lead to early detection of an underlying malignancy and prompt initiation of treatment, improving chances for a better outcome.

Entities:  

Keywords:  Anti-AMPA receptor (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) encephalitis; Anti-CV2/CRMP5 antibodies; Anti-Caspr2 encephalitis (contactin-associated protein-like 2); Anti-DNER (Delta/Notch-like epidermal growth factor-related receptor) antibodies; Anti-GABAbR (γ-aminobutyric acid receptor-B) encephalitis; Anti-Hu antibodies; Anti-Ma2 antibodies; Anti-glycine receptor (GlyR) antibodies; Anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis; Anti-mGLUR1 (metabotropic glutamate receptor 1); Anti-mGluR5 (metabotropic glutamate receptor 5); Autoimmune encephalitis; Limbic encephalitis; Morvan syndrome; N-methyl-D-aspartate receptor (NMDAR) encephalitis; Onconeuronal antibodies; Ophelia syndrome; Opsoclonus-myoclonus syndrome; Paraneoplastic cerebellar degeneration; Paraneoplastic encephalomyelitis; Paraneoplastic neurological syndromes; Progressive encephalomyelitis with rigidity and myoclonus; Stiff person syndrome

Mesh:

Substances:

Year:  2018        PMID: 30415318     DOI: 10.1007/s11912-018-0721-y

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  72 in total

1.  Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.

Authors:  P Sillevis Smitt; A Kinoshita; B De Leeuw; W Moll; M Coesmans; D Jaarsma; S Henzen-Logmans; C Vecht; C De Zeeuw; N Sekiyama; S Nakanishi; R Shigemoto
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

2.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

3.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

Review 4.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

Review 5.  Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis.

Authors:  Myrna R Rosenfeld; Josep O Dalmau
Journal:  Continuum (Minneap Minn)       Date:  2012-04

6.  "Limbic encephalitis" and its association with carcinoma.

Authors:  J A Corsellis; G J Goldberg; A R Norton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

7.  Burden of encephalitis-associated hospitalizations in the United States, 1998-2010.

Authors:  Neil M Vora; Robert C Holman; Jason M Mehal; Claudia A Steiner; Jesse Blanton; James Sejvar
Journal:  Neurology       Date:  2014-01-02       Impact factor: 9.910

8.  Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

Authors:  Helena Ariño; Thais Armangué; Mar Petit-Pedrol; Lidia Sabater; Eugenia Martinez-Hernandez; Makoto Hara; Eric Lancaster; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2016-07-27       Impact factor: 9.910

9.  Clinical analysis of anti-Ma2-associated encephalitis.

Authors:  Josep Dalmau; Francesc Graus; Alberto Villarejo; Jerome B Posner; Deborah Blumenthal; Brian Thiessen; Albert Saiz; Patricio Meneses; Myrna R Rosenfeld
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

10.  New estimates of incidence of encephalitis in England.

Authors:  Julia Granerod; Simon Cousens; Nicholas W S Davies; Natasha S Crowcroft; Sara L Thomas
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

View more
  13 in total

1.  Headache, Delirium or Encephalitis? A Case of Residual Mutism Secondary to Anti-NMDA Receptor Encephalitis.

Authors:  Omar Jiménez-Zarazúa; María Andrea Martínez-Rivera; Pedro Luis González-Carrillo; Lourdes N Vélez-Ramírez; María Alcocer-León; Sandra X L Tafoya-Rojas; Angélica M Becerra-Baez; Mariana A Bravo-Martínez; Jaime D Mondragón
Journal:  Case Rep Neurol       Date:  2019-12-06

Review 2.  Paraneoplastic syndrome in neuroophthalmology.

Authors:  Longdan Kang; Chao Wan
Journal:  J Neurol       Date:  2022-07-02       Impact factor: 6.682

3.  Anti-SOX1 antibody-associated acute hemorrhagic leukoencephalitis.

Authors:  Nicolas Lambert; Laurence Lutteri; Luaba Tshibanda; Elettra Bianchi; Pierre Maquet
Journal:  J Neurol       Date:  2022-01-24       Impact factor: 6.682

4.  Influence of Autoimmune Antibody Testing on the Use of Immunotherapy on an Inpatient Neurology Service.

Authors:  Kristin Galetta; Galina Gheihman; Amy Rosen; Joshua P Klein; Shamik Bhattacharyya
Journal:  Neurohospitalist       Date:  2020-12-07

5.  Limbic encephalitis associated with AMPA receptor and CRMP5 antibodies: A case report and literature review.

Authors:  Yujuan Jia; Jie Wang; Lanping Xue; Yuli Hou
Journal:  Brain Behav       Date:  2020-01-28       Impact factor: 2.708

Review 6.  Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.

Authors:  Jinhua Yan; Zhongbo Chen; Yumei Liang; Huijia Yang; Lizhi Cao; Yuling Zhou; Yang Zhao; Ying Zhang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

7.  Paraneoplastic encephalomyelitis revealing burned-out seminoma.

Authors:  Antoine Guilmot; Vincent van Pesch; Thierry Duprez; Philippe Jacquerye
Journal:  Acta Neurol Belg       Date:  2020-07-25       Impact factor: 2.396

8.  Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.

Authors:  Juan José Juárez-Vignon Whaley; Aurelio Carrera-Muiños; Karol Gema Hernandez-Gutierrez; Jerónimo Rafael Rodriguez-Cid; Maria Elisa Otero-Cerdeira; Vanessa Garcia-Montes
Journal:  Case Rep Oncol       Date:  2021-12-20

Review 9.  AQP4-IgG positive paraneoplastic NMOSD: A case report and review.

Authors:  Manqiu Ding; Yue Lang; Li Cui
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

Review 10.  Exosomes: A Friend or Foe for Osteoporotic Fracture?

Authors:  Zhimin Yang; Wenchao Zhang; Xiaolei Ren; Chao Tu; Zhihong Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.